{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:46:26Z","timestamp":1789519586838,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04474-0","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:28:14Z","timestamp":1762522094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of hospital pharmacist\u2013community pharmacist collaboration on solving pharmacotherapy problems in stroke patients with post-discharge transitions: non-randomized comparative study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuko","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misaki","family":"Kakihana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Kunita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Kanemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Sahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuko","family":"Onda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"4474_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/17474930241308142","volume":"20","author":"VL Feigin","year":"2025","unstructured":"Feigin VL, Brainin M, Norrving B, Martins SO, Pandian J, Lindsay P, et al. World stroke organization: global stroke fact sheet 2025. Int J Stroke. 2025;20:132\u201344. https:\/\/doi.org\/10.1177\/17474930241308142.","journal-title":"Int J Stroke"},{"key":"4474_CR2","unstructured":"Ministry of Health and Welfare. Summary of vital statistics 2022. 2022. https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/kakutei22\/dl\/10_h6.pdf. Accessed May 3, 2024."},{"key":"4474_CR3","unstructured":"Ministry of Health and Welfare. Summary report of a comprehensive survey of living conditions 2022. 2022. https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/k-tyosa\/k-tyosa22\/dl\/05.pdf. Accessed May 3, 2024."},{"key":"4474_CR4","unstructured":"Ministry of Health and Welfare. Summary of estimates of national medical care expenditure. 2021. https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/k-iryohi\/21\/dl\/kekka.pdf. Accessed May 3, 2024."},{"key":"4474_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105935","volume":"30","author":"M Kolmos","year":"2021","unstructured":"Kolmos M, Christoffersen L, Kruuse C. Recurrent ischemic stroke \u2013 a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2021;30:105935. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2021.105935.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"4474_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1161\/01.str.30.2.338","volume":"30","author":"GP Samsa","year":"1999","unstructured":"Samsa GP, Bian J, Lipscomb J, Matchar DB. Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. Stroke. 1999;30:338\u201349. https:\/\/doi.org\/10.1161\/01.str.30.2.338.","journal-title":"Stroke"},{"key":"4474_CR7","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2021;52:e364-467. https:\/\/doi.org\/10.1161\/STR.0000000000000375.","journal-title":"Stroke"},{"key":"4474_CR8","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1161\/STROKEAHA.106.475525","volume":"38","author":"DG Hackam","year":"2007","unstructured":"Hackam DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke. 2007;38:1881\u20135. https:\/\/doi.org\/10.1161\/STROKEAHA.106.475525.","journal-title":"Stroke"},{"issue":"9","key":"4474_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000382","volume":"52","author":"WN Kernan","year":"2021","unstructured":"Kernan WN, Viera AJ, Billinger SA, Bravata DM, Stark SL, Kasner SE, et al. Primary care of adult patients after stroke: a scientific statement from the American Heart Association\/American Stroke Association. Stroke. 2021;52(9):e558\u201371. https:\/\/doi.org\/10.1161\/STR.0000000000000382.","journal-title":"Stroke"},{"key":"4474_CR10","unstructured":"The stroke\/cerebrovascular and cardiovascular disease control act (Act No. 105 of December 14. 2018). https:\/\/houseikyoku.sangiin.go.jp\/bill\/pdf\/h30-105.pdf. Accessed May 6, 2024."},{"key":"4474_CR11","unstructured":"Ministry of Health, Labour and Welfare (MHLW). The summary of Pharmacy Vision for Patients. https:\/\/www.mhlw.go.jp\/file\/04-Houdouhappyou-11121000-Iyakushokuhinkyoku-Soumuka\/gaiyou_1.pdf. Accessed May 16, 2022."},{"key":"4474_CR12","first-page":"637","volume":"55","author":"R Suzuki","year":"2019","unstructured":"Suzuki R, Kakigoshi S, Sago K, Wakita E, Nakamura A, Hirano A, et al. Evaluation of information sharing between hospital pharmacists and community pharmacists using information liaison forms. J Jpn Soc Hosp Pharm. 2019;55:637\u201342.","journal-title":"J Jpn Soc Hosp Pharm"},{"key":"4474_CR13","first-page":"757","volume":"57","author":"Y Ishihara","year":"2021","unstructured":"Ishihara Y, Nishikori K, Fujihara R, Kageyama S, Funo Y, Ajiki K-I, et al. The Preparation and evaluation of discharge summaries containing a medication report specifying the reasons for changes in prescriptions. J Jpn Soc Hosp Pharm. 2021;57:757\u201364.","journal-title":"J Jpn Soc Hosp Pharm"},{"key":"4474_CR14","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1248\/yakushi.23-00214","volume":"144","author":"Y Fukuda","year":"2024","unstructured":"Fukuda Y, Suzuki M, Ito R, Inaba J, Kanemoto T, Sahara T, et al. Utilization and issues related to discharge medication summaries from hospital pharmacies to community pharmacies. Yakugaku Zasshi. 2024;144:741\u20138. https:\/\/doi.org\/10.1248\/yakushi.23-00214.","journal-title":"Yakugaku Zasshi"},{"key":"4474_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40780-025-00415-8","volume":"11","author":"Y Fukuda","year":"2025","unstructured":"Fukuda Y, Ito R, Kakihana M, Takahashi T, Kanemoto T, Sahara T, et al. Survey of medication history of patients with stroke after discharge from an acute hospital ward: a case series study. J Pharm Health Care Sci. 2025;11:10. https:\/\/doi.org\/10.1186\/s40780-025-00415-8.","journal-title":"J Pharm Health Care Sci"},{"key":"4474_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/STROKEAHA.112.678847","volume":"44","author":"C Hohmann","year":"2013","unstructured":"Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Adherence to hospital discharge medication in patients with ischemic stroke: a prospective, interventional 2-phase study. Stroke. 2013;44:522\u20134. https:\/\/doi.org\/10.1161\/STROKEAHA.112.678847.","journal-title":"Stroke"},{"key":"4474_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000369380","volume":"4","author":"U Hedegaard","year":"2014","unstructured":"Hedegaard U, Kjeldsen LJ, Potteg\u00e5rd A, Bak S, Hallas J. Multifaceted intervention including motivational interviewing to support medication adherence after stroke\/transient ischemic attack: a randomized trial. Cerebrovasc Dis Extra. 2014;4:221\u201334. https:\/\/doi.org\/10.1159\/000369380.","journal-title":"Cerebrovasc Dis Extra"},{"key":"4474_CR18","unstructured":"Medications covered by insurance dictionary plus\u2009+\u2009with indications and dosage, the NHI drug price standard by drug efficacy. 2022 ed. Tokyo: Jiho Yakugyo Kenkyukai; 2022."},{"key":"4474_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transplant"},{"key":"4474_CR20","unstructured":"Japan Atherosclerosis Society (JAS). Guidelines for prevention of atherosclerotic cardiovascular diseases 2022. Tokyo: Japan Atherosclerosis Society; 2022."},{"key":"4474_CR21","unstructured":"The Japan Stroke Society. Stroke guidelines Committee. Japanese guidelines for the management of STROKE 2021, e-book edition. Tokyo: Kyowa Planning Co; 2021."},{"key":"4474_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/2150131913518346","volume":"5","author":"J Hamano","year":"2014","unstructured":"Hamano J, Tokuda Y. Inappropriate prescribing among elderly home care patients in Japan: prevalence and risk factors. J Prim Care Community Health. 2014;5:90\u20136.","journal-title":"J Prim Care Community Health"},{"key":"4474_CR23","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.clinthera.2022.01.014","volume":"44","author":"JL Harris","year":"2022","unstructured":"Harris JL, DelVecchio D, Seabury RW, Miller CD, Phillips E. Pharmacists act on care transitions in stroke (PACT-stroke): a systems approach. Clin Ther. 2022;44:466\u201372. https:\/\/doi.org\/10.1016\/j.clinthera.2022.01.014.","journal-title":"Clin Ther"},{"key":"4474_CR24","unstructured":"Ministry of Health and Welfare. Guidelines for the appropriate use of medicines in the elderly 2018. https:\/\/www.mhlw.go.jp\/content\/11121000\/kourei-tekisei_web.pdf. Accessed Sept 15, 2024."},{"key":"4474_CR25","unstructured":"Japanese Society of Stroke. Decision Support Manual for Stroke Treatment. (Japanese Society of Stroke, 2021) https:\/\/www.jsts.gr.jp\/img\/decision_support_manual.pdf. Accessed June 25, 2025."},{"key":"4474_CR26","unstructured":"Japanese Society of Stroke. Stroke Consultation Manual ver.4. (Japanese Society of Stroke, 2025) https:\/\/www.jsts.gr.jp\/img\/consultation_manual_ver4.0.pdf Accessed Sep 19, 2025."},{"key":"4474_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-8-59","volume":"8","author":"C Hohmann","year":"2010","unstructured":"Hohmann C, Radziwill R, Klotz JM, Jacobs AH. Health-related quality of life after ischemic stroke: the impact of pharmaceutical interventions on drug therapy (pharmaceutical care concept). Health Qual Life Outcomes. 2010;8:59. https:\/\/doi.org\/10.1186\/1477-7525-8-59.","journal-title":"Health Qual Life Outcomes"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04474-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04474-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04474-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:28:20Z","timestamp":1762522100000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04474-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4474"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04474-0","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.\u3000The study was conducted in accordance with the \u201cEthical Guidelines for Medical and Biological Research Involving Human Subjects\u201d with approvals of the clinical research review board of JCHO Hoshigaoka Medical Center (approval number: No. 2346) and Ethics Committee of Osaka Medical and Pharmaceutical University (approval number: 2024-025).Informed consent was obtained from all individual participants included in the study. Before commencing the study, we distributed the briefing document, with the approval of the clinical research review board, to the study participants and obtained their voluntary written consent to participate in this study. Patients with the target diseases were likely to include those with communication difficulties. Therefore, we received consent from a proxy if it was deemed difficult for the patient to make a decision. Proxies refer to spouses, parents, siblings, children\/grandchildren, grandparents, relatives living together, or those considered to be equivalent to close relatives, the research subjects\u2019 representatives (including legal guardians with power of attorney) and individuals with whom they had a spiritual relationship, such as a partnership or trust.In the baseline survey conducted with the control group, participants were explained using a written document that their data might be used secondarily for future studies, and that such use would be subject to renewed approval by the ethics committee. Consent was obtained accordingly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"459"}}